AUSTIN, Texas and DUBAI, UAE (Arab Newswire) -- Nano Cures Inc. (“Nano”), a clinical stage biotechnology and infectious disease immunity platform company, today announced a
$90M pre-IPO funding round. The investment will be led by a $20M commitment from Opulence Capital Management, a Dubai based private investment fund, with existing and new investors participating.
The investment will...
O LianaPress fornece uma extensa lista de comunicados de imprensa e materiais de meios de comunicação
© Liana Technologies